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ABSTRACT. Transcranial magnetic stimulation (TMS) is a safe and effective treat- 
ment of treatment resistant major depressive disorder (MDD). However, MDD is a 
chronic disorder and relapse is common. The leading method of managing those cases 
of MDD who respond to TMS, but continue to relapse, is to provide maintenance 
TMS – short courses of 5 treatments over 2.5 days, repeat at monthly (or greater) 
intervals. The strategy is to increase the interval between treatment clusters and for 
patients to be discharged when they have been able to remain well for a couple of 
months. However, patients and doctors are both frequently apprehensive about 
increasing the between cluster interval, and patients tend to remain in treatment 
programs for long periods. We present a protocol and instrument to assist in moving 
from treatment to discharge, which we have found helpful. 
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Risk of Relapse in Major Depressive Disorder (MDD) 
 
Patients suffering major depressive disorder (MMD) come to transcranial 
magnetic stimulation (TMS) after they have failed to respond to other treat- 
ments (psychotherapy, pharmacotherapy). Patients who have failed to respond 
to any form of treatment of depression are at high risk of relapse (Rush et al., 
2006). Relapse following the cessation of antidepressant medication is com- 
mon (Berwain et al., 2017). Resistance to antidepressant medication predicts 
a less favorable clinical response to TMS and ECT (Purdic et al., 1996).   
Also, relapse following successful ECT is a major challenge (Kellner, 
2013). A meta-analysis of ECT outcome reports that following successful 
treatment, 27.1% of patients have relapsed at 3 months, 34% at 6 months, 
and 51.1% at 12 months (Jelovac et al., 2013). Following successful treat- 
ment, TMS has a very similar relapse rate – with 33.5%, relapsing after 3 
months, 47.1% after 6 months, and 57% relapsing at 12 months (Senova et 
al., 2019).  
That relapse occurs after the cessation of a successful course of TMS 
does not indicate that TMS is an ineffective treatment (as we have seen 
above, a similar relapse rate follows the cessation of successful ECT) – such 
relapses simply indicate that the disease process is virulent. Thus, on-going 
strenuous treatment is justified. 
Following successful courses of ECT, remission maintenance programs 
provide further ECT treatments, on a less frequent basis. A common protocol 
(following a successful acute course) is for a single treatment to be provided 
on a weekly basis, then two weekly, and eventually one ECT treatment may 
be provided at monthly intervals (Fink et al., 1996). 
 
Cluster Maintenance TMS 
 
A comparable treatment process has been described when relapse has occurred 
soon after a successful acute course of TMS. This is termed “clustered main- 
tenance TMS” (Fitzgerald et al., 2013). Following a second successful acute 
course of TMS, at intervals of at least 4 weeks, patients receive clusters of 5 
TMS treatments over 2.5 days. 
Fitzgerald et al. (2013) reported an open study of 35 patients who had 
completed a successful acute course, but soon relapsed. One month following 
a second successful acute course, clustered maintenance TMS was instituted. 
Comparing the time to relapse following the first and the second acute courses, 
clustered maintenance TMS substantially delayed relapse. More recently, in a 
large randomized controlled trial, clustered maintenance TMS was signif- 
icantly more effective in preventing relapse than antidepressant medication 
(Wang et al., 2017). Our group found cluster maintenance TMS at monthly 
and greater intervals restores remission when patients are drifting into relapse 
(Pridmore et al., 2018). 
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Time between Clusters of Treatment 
 
The time between clusters starts at one month (Fitzgerald et al., 2013; Wang 
et al., 2017) and generally increases. Our group reported 14 patients who had 
been maintained well for more than 12 months (Pridmore and May, 2018) – 
the time between clusters commenced at one month and was lengthened, 
over the year, to a mean 5.4(0.8) weeks. We believe that if we had used the 
protocol described herein, that interval would have been much greater. 
The maintenance of remission is desirable – it means less episodes of 
pain/suffering for patients, and longer symptom free periods are associated 
with lower risk of further relapse/recurrence (Furukawa et al., 2008). 
Increasing the time between clusters reduces cost and patient inconven- 
ience. However, while somewhat inconvenient, many patients find attendance 
for clustered TMS to be pleasant – they meet familiar, skilled staff, receive 
cutting-edge treatment, and achieve a lift in mood. Also, recent treatment is 
reassuring, it is insurance against an imminent relapse. Therefore, some 
patients are reluctant to increase the time between clusters.  
Treating clinicians are also often concerned that increasing the time be- 
tween clusters beyond (an unknown) critical point may diminish the protective 
effect of the program and allow relapse. An administrative concern is that 
failure to extend the time between clusters for individual patients can mean 
the provision of unnecessary (wasteful) service to some, and the blocking of 
service to new patients in need of such care. 
To this point, no strategy has been available to assist us in grading the 
patient’s well-being during (and thereby increasing) the interval between 
clusters of TMS treatments. It is not uncommon for centers providing this 
treatment to have a group of patients who have been receiving clustered 
TMS at monthly intervals for long periods without the need for such intense 
treatment having been tested. 
 
The Mood Log 
 
To efficiently plan clustered maintenance TMS, we needed to gain insight 
into the mental state of patients during the weeks between clusters of treat- 
ment. We developed a “Mood Log” – a subjective mood rating scale which 
is completed on a weekly basis and brought along to the clinic when the 
patient returns for the next cluster of treatment. The Mood Log is a stack of 
horizontal strips of 10 boxes running from the anchor point “no depression” 
on the left of a page across to “most depression” on the right. The staff 
attach dates to the strips to remind patients when they should be scored. 
Some patients set an alarm on their telephone to remind them to complete 
this task. 
The interval between the acute course and the first cluster of maintenance 
TMS is four weeks. Thus, when patients complete an acute course, they are 
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given a page with at least 4 rating strips, to be scored and returned as stated. 
The interval between the first and second clustered maintenance TMS is 
determined by the Mood Log scores made between the acute treatment and 
the first cluster of treatment. And so on, the scores of the previous interval 
direct the length of the next interval. 
On completion of a successful acute course or a maintenance cluster of 
TMS, the subjective depression rating score is usually around 2. Over sub- 
sequent weeks a wide variety of ratings is possible, but two patterns are com- 
mon. First – little change from week to week with most scores are around 2 
(remaining well) (Fig. 1). Second – each week the score grows by 1 or 2, so 
that at four weeks (for example), the score is about 5 (mood deterioration) 
(Fig. 2).  
 
Discharge from the Program 
 
If the Mood Log scores remain in the region of 2 and 3, we frequently 
attempt to increase the inter-cluster interval. If the Mood Log scores increase 
and are greater than 3, in general, we do not increase the time between 
clusters, but repeat the recently completed interval. With this protocol of 
extending the interval when the subjective depression scores show little 
change and repeating the recent interval when there is evidence of higher 
subjective depression scores, we work towards a successful 8-week interval 
and possible discharge. 
When patients have remained relatively symptom-free for 8 weeks, they 
may request discharge on condition that they can receive further treatment, if 
needed, in the future. An apprehensive patient may not make this request, in 
which case, the staff may suggest further treatment does not appear necessary 
at that time. Another 8-week interval followed by a further cluster of treat- 
ment, may be appropriate. Unfortunately, with chronic relapsing MDD, a 
period of equanimity may not persist, despite promising indicators 
After more than 5 years of providing clustered maintenance TMS we had 
discharged more than 30 patients (65% female) and were still providing 
(beyond 6 months) clustered maintenance to 35 (70% female) patients. The 
Mood Log assisted those patients and the treating clinicians in better man- 
aging the situation. We were able to lengthen the between cluster interval for 
many and to discharge 10 (28%).   
At the moment there is evidence that some patients will need to remain in 
treatment for an extended period of time – here, the aim is to reduce the 
amount of treatment to a safe minimum (by safely extending the interval 
between clusters of treatment). 
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Conclusion 
 
MDD is frequently a relapsing condition. TMS is frequently effective in acute 
treatment. Clustered maintenance TMS is helpful in providing frequently 
relapsing patients with longer periods of remission. However, patients may 
remain in maintenance programs for unnecessarily long periods. Both patients 
and clinicians are reluctant to discontinue maintenance treatment. Having 
quantitative information about the patient’s subjective experience over the 
weeks between treatment clusters can help greatly in clinical judgement and 
planning. The Mood Log is a tool which provides a structured, regular (weekly) 
subjective mood score, which is a useful indicator of the near future, and a 
quantitative data set which can be used in discussion and planning. 
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Table 1 Mood Log results over a 7 week period. There had been little change in the 
subjective depression scores, reaching a maximum of 2. The between cluster interval, 
for this patient, was increased by one week (to 8 weeks). 
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Table 2 Mood Log results over a 7 week period. There had been progressive in- 
crease in the subjective depression scores, reaching a maximum of 7. After the 
cluster of TMS the score fell again to 3. For this patient, the interval between 
clusters was not altered – the next cluster being scheduled after a further 7 weeks. 
 
 
